Narix Pharmaceuticals Private Limited

Ivermectin Tablet Broad-Spectrum Antiparasitic for Strongyloidiasis, River Blindness & Scabies Narix Pharmaceuticals Narix Pharmaceuticals manufactures Ivermectin Tablets in multiple strengths (24 mg, 40 mg, 80 mg) for high-weight patient dosing, mass drug administration programs, and specialized parasitic infection management. Key Therapeutic Uses: � Strongyloidiasis � intestinal nematode infection � Onchocerciasis (river blindness) � WHO MDA program � Scabies and crusted scabies � oral high-dose � Lymphatic filariasis � MDA component � Pediculosis (head lice) � oral treatment � Tropical eosinophilia and loiasis Available Strengths: 3 mg 6 mg 12 mg 24 mg 40 mg 80 mg Product Highlights: � WHO essential medicine � EML listed antiparasitic � Mass drug administration dosing strengths available � WHO-GMP, DCGI approved � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #IvermectinTablet #AntiparasiticTablet #AnthelminticTablet #StrongyloidiasisTablet #ScabiesMedicine #MDAProgram #IvermectinManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Ansimar (Doxofylline) Tablet Safer Next-Generation Xanthine Bronchodilator for Asthma & COPD Narix Pharmaceuticals Narix Pharmaceuticals manufactures Doxofylline Tablets, a next-generation xanthine with bronchodilator efficacy comparable to theophylline but with significantly better tolerability � no cardiovascular or CNS stimulation at therapeutic doses. Key Therapeutic Uses: � Bronchial asthma � mild to moderate persistent � COPD � bronchodilator maintenance � Nocturnal asthma � sustained-release formulation � Chronic bronchitis with bronchospasm Available Strengths: 400 mg 800 mg SR Product Highlights: � No cardiovascular or CNS stimulation vs theophylline � Very high prescription volume in India � SR formulation for twice-daily dosing � WHO-GMP, DCGI approved � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #DoxofyllineTablet #AnsimarGeneric #DoxobidGeneric #XanthineBronchodilator #AsthmaTablet #COPDMedicine #DoxofyllineManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Mebendazole 500mg Tablet WHO Essential Anthelmintic for Soil-Transmitted Helminths & MDA Narix Pharmaceuticals Narix Pharmaceuticals manufactures Mebendazole 500 mg Tablets, a benzimidazole anthelmintic that blocks glucose uptake in parasites � the WHO-recommended single-dose treatment for soil-transmitted helminthiasis in MDA programs and one of the most widely distributed antiparasitic drugs globally. Key Therapeutic Uses: � Soil-transmitted helminthiasis � WHO MDA single dose 500 mg � Ascariasis, trichuriasis, hookworm � all covered by single dose � Enterobiasis (pinworm) � treatment and prevention � Trichinellosis � high-dose treatment � Echinococcosis (hydatid disease) � long-term therapy Available Strengths: 100 mg 500 mg Product Highlights: � WHO essential medicine � global MDA backbone drug � Single 500 mg dose � WHO recommended for STH � WHO-GMP, DCGI approved � Very high export demand for national deworming programs � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #MebendazoleTablet #VermoxGeneric #WorminGeneric #AnthelminticTablet #SoilTransmittedHelminths #MDAProgram #DewormiingTablet #MebendazoleManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

 

Canagliflozin Tablets 100 mg are prescription medicines used in the management of type 2 diabetes mellitus under medical supervision. The active ingredient, Canagliflozin 100 mg, belongs to the class of SGLT2 (sodium-glucose co-transporter-2) inhibitors and works by reducing glucose reabsorption in the kidneys, helping excess sugar leave the body through urine. This action assists in controlling blood sugar levels and also supports cardiovascular and kidney health in diabetic patients. These tablets are commonly prescribed as part of long-term diabetes management along with diet and lifestyle control.

Canagliflozin 100 mg tablets are widely used in endocrinology and diabetic care due to their clinically proven effectiveness and global therapeutic acceptance. International buyers frequently search for this product using terms such as Canagliflozin tablets exporter, Canagliflozin 100 mg supplier, SGLT2 inhibitor tablets wholesale, diabetes treatment medicine, type 2 diabetes tablets supplier, antidiabetic medicines exporter, and diabetic pharmaceutical supplier from India. With the rising global prevalence of diabetes, Canagliflozin tablets remain a high-demand product in international pharmaceutical markets.

Manufactured in accordance with international pharmaceutical quality standards, Canagliflozin Tablets 100 mg comply with IP, BP, or USP specifications as applicable. The tablets are supplied in original, sealed, export-quality packaging suitable for hospital use and international pharmaceutical distribution. Importers prefer sourcing Canagliflozin tablets from trusted exporters who provide authentic products with complete regulatory and quality documentation.

Applications
Canagliflozin Tablets 100 mg are supplied to hospitals, diabetic clinics, endocrinology centers, general healthcare institutions, and pharmaceutical distribution networks. They are commonly procured by hospital pharmacies, medical wholesalers, and international importers dealing in antidiabetic and chronic disease management medicines. The product is intended strictly for use under the supervision of qualified healthcare professionals.

Usage & Storage
Canagliflozin Tablets 100 mg should be used strictly as prescribed by a licensed medical practitioner. Dosage and duration of treatment depend on the patient’s clinical condition and glycemic response. Tablets should be stored in a cool, dry place away from direct sunlight and moisture to maintain stability during storage and international transport.

Export & Supply
Narix Pharmaceuticals Pvt Ltd is a trusted exporter and supplier of Canagliflozin Tablets 100 mg from India, supplying genuine antidiabetic medicines to international buyers. We export Canagliflozin tablets to markets including USA, UK, Australia, Vietnam, Singapore, and other global destinations. Our company supports pharmaceutical importers, hospital suppliers, and distributors seeking reliable sources of diabetes medicines from India.

Narix Pharmaceuticals Pvt Ltd provides complete export documentation, secure packaging, and dependable logistics support in compliance with international trade requirements. We support bulk supply, consistent availability, and long-term partnerships with competitive export pricing.

Why Choose Us
Buyers searching for Canagliflozin Tablets 100 mg exporter, antidiabetic medicine supplier India, diabetes tablets wholesale, type 2 diabetes medicine exporter, SGLT2 inhibitor supplier, or pharmaceutical diabetes medicines exporter can rely on Narix Pharmaceuticals Pvt Ltd for authentic products, consistent quality, timely dispatch, and professional export service. Our strong focus on quality assurance, regulatory compliance, and global pharmaceutical supply makes us a dependable partner for Canagliflozin tablet exports worldwide.

Anafranil (Clomipramine) Tablet Most Potent Anti-OCD Pharmacotherapy Narix Pharmaceuticals Narix Pharmaceuticals manufactures Clomipramine Tablets, the most potent serotonergic TCA and most efficacious drug for OCD � with proven superiority over SSRIs in severe and refractory OCD cases. Key Therapeutic Uses: � OCD � most effective pharmacotherapy � Major depressive disorder when SSRIs fail � Panic disorder � Cataplexy in narcolepsy � Body dysmorphic disorder and phobias Available Strengths: 10 mg 25 mg 50 mg 75 mg Product Highlights: � Most efficacious OCD drug � long clinical history � WHO-GMP, DCGI approved � Alu-Alu blister packs, bulk export � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #ClomipramineTablet #AnafranilGeneric #OCDMedicine #TricyclicAntidepressant #AntiOCDTablet #ClomipramineManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Zinconia (Zinc Sulfate) Tablet Essential Trace Mineral for Immunity, Growth & Wound Healing Narix Pharmaceuticals Narix Pharmaceuticals manufactures Zinc Sulfate Tablets, an essential trace mineral supplement with roles in immune function, wound healing, growth, and male reproductive health � the most prescribed zinc supplement in India. Key Therapeutic Uses: � Zinc deficiency � growth retardation in children � Acute diarrhea in children � WHO recommended (10-20 mg x 14 days) � Wound healing support � post-surgical and chronic wounds � Male infertility � sperm quality improvement � Common cold duration reduction � Wilson's disease � maintenance therapy Available Strengths: 10 mg 20 mg 50 mg Product Highlights: � WHO recommended for pediatric diarrhea � WHO essential medicine � zinc supplementation � WHO-GMP, DCGI approved � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #ZincSulfateTablet #ZinconiaGeneric #ZincSupplementTablet #PediatricDiarrhea #ImmuneBooster #ZincManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Arcoxia (Etoricoxib) Tablet Most Potent Selective COX-2 Inhibitor for Arthritis & Acute Pain Narix Pharmaceuticals Narix Pharmaceuticals manufactures Etoricoxib Tablets, the most potent and selective COX-2 inhibitor commercially available � with superior GI safety, once-daily dosing, and proven efficacy across osteoarthritis, rheumatoid arthritis, gouty arthritis, and acute pain. Key Therapeutic Uses: � Osteoarthritis and rheumatoid arthritis � once-daily management � Gouty arthritis � acute flare treatment (120 mg) � Ankylosing spondylitis � Acute post-surgical and dental pain � Primary dysmenorrhea Available Strengths: 30 mg 60 mg 90 mg 120 mg Product Highlights: � Most selective COX-2 inhibitor � best GI safety among NSAIDs � Once-daily dosing � highest compliance � WHO-GMP, DCGI approved � Very high prescription volume in India � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #EtoricoxibTablet #ArcoxiaGeneric #NucoxiaGeneric #SelectiveCOX2 #ArthritisTablet #GoutTablet #EtoricoxibManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine #NSAIDSafe

Ventolin (Salbutamol) Tablet World's Most Prescribed Bronchodilator Narix Pharmaceuticals Narix Pharmaceuticals manufactures Salbutamol Tablets, the most widely prescribed selective short-acting beta-2 adrenergic agonist � WHO essential medicine used globally for asthma and COPD bronchospasm relief. Key Therapeutic Uses: � Bronchial asthma � acute and oral maintenance � COPD � bronchospasm relief � Exercise-induced bronchospasm � Hyperkalemia � rapid K+ lowering (IV) � Preterm labor tocolysis (off-label) Available Strengths: 2 mg 4 mg SR 4/8 mg Product Highlights: � WHO essential medicine � most prescribed bronchodilator � Available as tablets, SR, inhaler, nebulizer, and IV � Extremely high export demand globally � WHO-GMP, DCGI approved � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #SalbutamolTablet #VentolinGeneric #AsthalinGeneric #Beta2Agonist #BronchodilatorTablet #AsthmaTablet #SalbutamolManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine #EssentialMedicine

Enablex (Darifenacin) Tablet Highly Selective M3 Antimuscarinic for OAB Narix Pharmaceuticals Narix Pharmaceuticals manufactures Darifenacin Tablets, the most M3-selective antimuscarinic available � providing effective overactive bladder control with significantly lower cognitive and salivary side effects due to its selectivity away from M1 and M2 receptors. Key Therapeutic Uses: � Overactive bladder (OAB) � urgency, frequency, urge incontinence � Urge urinary incontinence � Neurogenic detrusor overactivity � OAB in elderly � preferred for low CNS effects Available Strengths: 7.5 mg 15 mg ER Product Highlights: � Highest M3 selectivity � lowest CNS and cardiac effects � Once-daily ER formulation � WHO-GMP, DCGI approved � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #DarifenacinTablet #EnablexGeneric #HighlySelectiveM3 #OABTablet #UrgeIncontinence #DarifenacinManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Bambec (Bambuterol) Tablet Prodrug Beta-2 Agonist for Once-Daily Asthma & COPD Narix Pharmaceuticals Narix Pharmaceuticals manufactures Bambuterol Tablets, a carbamic acid ester prodrug of terbutaline � the only oral beta-2 agonist requiring once-daily dosing, providing sustained 24-hour bronchodilation through slow in-vivo conversion. Key Therapeutic Uses: � Bronchial asthma � once-daily oral bronchodilator � COPD � oral maintenance bronchodilator � Nocturnal asthma � once-nightly dosing � Patients unable to use inhaled beta-agonists Available Strengths: 10 mg 20 mg Product Highlights: � Only once-daily oral beta-2 agonist in class � Sustained 24-hour bronchodilation � WHO-GMP, DCGI approved � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #BambuterolTablet #BambecGeneric #OnceDailyBeta2Agonist #AsthmaTablet #COPDTablet #OralBronchodilator #BambuterolManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Tonoferon (Carbonyl Iron + Folic Acid + B12) Tablet Triple Nutritional Supplement for Anemia Narix Pharmaceuticals Narix Pharmaceuticals manufactures Carbonyl Iron + Folic Acid + Vitamin B12 FDC Tablets � a comprehensive triple nutritional supplement addressing all three major nutrient deficiency anemias simultaneously. Key Therapeutic Uses: � Combined iron, folate, and B12 deficiency anemia � Pregnancy and postpartum nutritional supplementation � Elderly multi-deficiency anemia � CKD nutritional anemia � Post-bariatric surgery nutritional support Available Strengths: Carbonyl Iron 100 mg + Folic Acid 1.5 mg + B12 15 mcg Product Highlights: � Triple deficiency coverage � single tablet � Carbonyl iron � elemental iron, minimal GI side effects � WHO-GMP, DCGI approved � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #CarbonylIronFolicB12Tablet #TonoferoGeneric #FerotabGeneric #TripleAnemiaSupplement #IronDeficiencyAnemia #PregnancySupplementTablet #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Vesicare (Solifenacin) Tablet Selective M3 Antimuscarinic for Overactive Bladder & Urge Incontinence Narix Pharmaceuticals Narix Pharmaceuticals manufactures Solifenacin Tablets, a selective M3 muscarinic receptor antagonist for the treatment of overactive bladder (OAB) � reducing urinary urgency, frequency, and urge incontinence with once-daily dosing and favorable tolerability. Key Therapeutic Uses: � Overactive bladder (OAB) � urgency, frequency, urge incontinence � Urge urinary incontinence � first-line antimuscarinic � Neurogenic overactive bladder � spinal cord injury, MS � Nocturia associated with OAB Available Strengths: 5 mg 10 mg Product Highlights: � M3 selective � lower dry mouth than non-selective antimuscarinics � Once-daily dosing � high compliance � WHO-GMP, DCGI approved � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #SolifenacinTablet #VesicareGeneric #SolitenGeneric #AntimuscarinicTablet #OveractiveBladder #UrgeIncontinence #SolifenacinManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Doxobid A-(Doxofylline + Ambroxol) Tablet Bronchodilator + Mucolytic FDC for Asthma with Productive Cough Narix Pharmaceuticals Narix Pharmaceuticals manufactures Doxofylline + Ambroxol FDC Tablets combining xanthine bronchodilation with secretolytic mucolysis � simultaneous airway dilation and mucus clearance for asthma/COPD with productive cough. Key Therapeutic Uses: � Asthma with productive cough � COPD with mucus hypersecretion � Acute exacerbation of chronic bronchitis � Bronchospasm with viscous secretions Available Strengths: Doxofylline 400 mg + Ambroxol 30 mg Product Highlights: � Dual mechanism � bronchodilation + mucolysis � Better tolerability than theophylline-based FDCs � WHO-GMP, DCGI approved � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #DoxofyllineAmbroxolTablet #DoxobidAGeneric #BronchodilatorMucolyticFDC #AsthmaTablet #COPDCough #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Tindamax (Tinidazole) Tablet Superior Nitroimidazole for Trichomoniasis, Giardia & Amoebiasis Narix Pharmaceuticals Narix Pharmaceuticals manufactures Tinidazole Tablets, a second-generation nitroimidazole with longer half-life (12-14 hours) and better tissue penetration than metronidazole, enabling simpler once-daily regimens. Key Therapeutic Uses: � Trichomoniasis � single-dose treatment (2g) � Giardiasis � superior to metronidazole � Amoebiasis � intestinal and extra-intestinal � Bacterial vaginosis � single-dose effective � H. pylori eradication (combination regimen) Available Strengths: 300 mg 500 mg 1000 mg Product Highlights: � Once-daily or single-dose � superior compliance vs metronidazole � WHO-GMP, DCGI approved � Available standalone and in FDCs � Bulk export & PCD pharma franchise Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #TinidazoleTablet #TindamaxGeneric #NitroimidazoleAntibiotic #TrichomoniasisTablet #GiardiasisMedicine #AmoebicDysentery #TinidazoleManufacturer #AntibioticTablet #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Zyvox TB (Linezolid) Tablet WHO Group A Core Drug for MDR-TB BPaL Regimen Narix Pharmaceuticals Narix Pharmaceuticals supplies Linezolid 600 mg Tablets for MDR-TB treatment � the third component of the landmark BPaL (Bedaquiline + Pretomanid + Linezolid) regimen achieving 90% cure in XDR-TB in the ZeNix trial. Linezolid is now WHO Group A (highest priority) for MDR-TB. Key Therapeutic Uses: � MDR-TB and XDR-TB � WHO Group A core drug � BPaL regimen � Bedaquiline + Pretomanid + Linezolid � NTM (non-tuberculous mycobacteria) � combination therapy � MDR-TB in HIV coinfected patients Available Strengths: 400 mg 600 mg Product Highlights: � WHO Group A MDR-TB core drug � highest priority � BPaL regimen component � 90% XDR-TB cure � 100% oral bioavailability � tablet = IV � WHO-GMP, DCGI approved � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #LinezolidTBTablet #ZyvoxTBGeneric #WHOGroupAMDRTB #BPaLRegimen #XDRTBMedicine #LinezolidManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Lynparza (Olaparib) Tablet First-in-Class PARP Inhibitor for BRCA-Mutated Cancers Narix Pharmaceuticals Narix Pharmaceuticals supplies Olaparib Tablets, the first-in-class PARP inhibitor exploiting synthetic lethality in BRCA1/2-mutated cancers � approved for ovarian, breast, prostate, and pancreatic cancers with BRCA mutations, revolutionizing precision oncology. Key Therapeutic Uses: � BRCA-mutated ovarian cancer � maintenance after platinum � BRCA-mutated metastatic breast cancer � BRCA-mutated metastatic prostate cancer � BRCA-mutated metastatic pancreatic cancer Available Strengths: 100 mg 150 mg Product Highlights: � First-in-class PARP inhibitor � pioneer of synthetic lethality � Approved across 4 tumor types (BRCA-mutated) � WHO-GMP, DCGI approved � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #OlaparibTablet #LynparzaGeneric #OlanibGeneric #PARPInhibitor #BRCAMutatedCancer #OvarianCancerTablet #BreastCancerTablet #OlaparibManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Oseni (Alogliptin + Pioglitazone) Tablet Dual DPP-4 + TZD Combination for T2DM Narix Pharmaceuticals Narix Pharmaceuticals manufactures Alogliptin + Pioglitazone FDC combining DPP-4 inhibition with PPAR-gamma agonist for complementary glucose-lowering with insulin sensitization. Key Therapeutic Uses: � T2DM inadequately controlled on either agent alone � Insulin resistance with suboptimal DPP-4 response � T2DM with NAFLD/NASH � pioglitazone benefit � Post-ACS T2DM patients Available Strengths: Alogliptin 12.5/25 mg + Pioglitazone 15/30/45 mg Product Highlights: � Complementary dual mechanism � incretin + insulin sensitization � WHO-GMP, DCGI approved FDC � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #AlogliptinPioglitazoneTablet #OseniGeneric #DPP4TZDCombo #FDCDiabetes #DiabetesMedicine #AntidiabeticFDC #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Precose (Acarbose) Tablet Alpha-Glucosidase Inhibitor for Postprandial Glucose Narix Pharmaceuticals Narix Pharmaceuticals manufactures Acarbose Tablets, an alpha-glucosidase inhibitor that delays carbohydrate digestion in the small intestine, reducing postprandial blood glucose without stimulating insulin secretion. Key Therapeutic Uses: � Type 2 Diabetes � postprandial glucose control � Pre-diabetes / impaired glucose tolerance prevention � Add-on to Metformin, sulfonylureas, or insulin � Patients preferring gut-specific non-systemic mechanism Available Strengths: 25 mg 50 mg 100 mg Product Highlights: � No systemic absorption � acts locally in gut � No hypoglycemia risk as monotherapy � WHO-GMP, DCGI approved � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #AcarboseTablet #PrecoseGeneric #GlucobayGeneric #AlphaGlucosidaseInhibitor #PostprandialGlucose #DiabetesMedicine #AcarboseManufacturer #AntidiabeticTablet #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Valtrex (Valacyclovir) Tablet Prodrug of Acyclovir for Herpes, Cold Sores & Shingles Narix Pharmaceuticals Narix Pharmaceuticals manufactures Valacyclovir Tablets, the L-valyl ester prodrug of acyclovir with 3-5x higher oral bioavailability � enabling less frequent dosing for herpes simplex, herpes zoster, and genital herpes management. Key Therapeutic Uses: � Herpes zoster (shingles) � accelerates healing, reduces postherpetic neuralgia � Genital herpes � episodic and suppressive therapy � Herpes labialis (cold sores) � reduces duration and recurrence � HSV encephalitis � oral step-down from IV acyclovir � CMV prophylaxis in transplant recipients (high dose) Available Strengths: 500 mg 1000 mg Product Highlights: � 3-5x higher bioavailability than oral acyclovir � Fewer doses required � superior compliance � WHO-GMP, DCGI approved � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #ValacyclovirTablet #ValtrexGeneric #ValcivirGeneric #HerpesTablet #ShinglesTablet #ColdSoreTablet #ValacyclovirManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine #AntiviralTablet

Avapro (Irbesartan) Tablet ARB with Renoprotective Benefits for Hypertension & Diabetic Nephropathy Narix Pharmaceuticals Narix Pharmaceuticals manufactures Irbesartan Tablets, an AT1 receptor antagonist ARB with proven renoprotective benefits in type 2 diabetic nephropathy (IDNT trial). Well-tolerated with no ACE inhibitor-related cough. Key Therapeutic Uses: � Hypertension � monotherapy or combination � Type 2 diabetic nephropathy with proteinuria � Heart failure � alternative to ACE inhibitors � Cardiovascular risk reduction Available Strengths: 75 mg 150 mg 300 mg Product Highlights: � No ACE inhibitor-associated cough � WHO-GMP, DCGI approved manufacturing � Available with HCTZ FDC for resistant hypertension � Bulk export & PCD pharma franchise Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #IrbesartanTablet #AvaproGeneric #ARBTablet #AntihypertensiveTablet #DiabeticNephropathy #IrbesartanManufacturer #CardiacMedicine #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Atacand (Candesartan) Tablet Potent Long-Acting ARB for Hypertension & Heart Failure Narix Pharmaceuticals Narix Pharmaceuticals manufactures Candesartan Tablets, a potent long-acting ARB with the highest receptor binding affinity in class. CHARM trial demonstrated significant mortality reduction in HFrEF. Key Therapeutic Uses: � Hypertension � 24-hour once-daily control � Heart failure with reduced ejection fraction (HFrEF) � mortality benefit � Left ventricular dysfunction post-MI � Diabetic nephropathy protection Available Strengths: 4 mg 8 mg 16 mg 32 mg Product Highlights: � Highest receptor affinity in ARB class � WHO-GMP, DCGI approved manufacturing � Alu-Alu blister packs, bulk export ready � PCD pharma franchise & third-party manufacturing Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #CandesartanTablet #AtacandGeneric #ARBTablet #AntihypertensiveTablet #HeartFailureMedicine #CandesartanManufacturer #CardiacMedicine #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Coartem (Artemether + Lumefantrine) Tablet WHO First-Line ACT for Uncomplicated Malaria Narix Pharmaceuticals Narix Pharmaceuticals manufactures Artemether + Lumefantrine FDC Tablets, the WHO first-line Artemisinin Combination Therapy (ACT) for uncomplicated Plasmodium falciparum malaria � providing rapid parasite clearance (artemether) with sustained elimination (lumefantrine). Key Therapeutic Uses: � Uncomplicated Plasmodium falciparum malaria � WHO first-line � Multi-drug resistant falciparum malaria � Mixed Plasmodium infections Available Strengths: Artemether 20 mg + Lumefantrine 120 mg (pediatric and adult) Product Highlights: � WHO first-line ACT � global malaria treatment standard � WHO essential medicine � EML listed � 3-day 6-dose regimen � high compliance � WHO-GMP, DCGI approved � High export to Africa, ASEAN malaria-endemic regions � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #ArtemetheLumefantrineTablet #CoartemGeneric #LumeraxGeneric #ACTMalarial #FalciparumMalaria #ArtemisinCombinationTherapy #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Sirturo (Bedaquiline) Tablet First-in-Class ATP Synthase Inhibitor for MDR-TB Narix Pharmaceuticals Narix Pharmaceuticals supplies Bedaquiline Tablets, the first new TB drug class in 40 years � a diarylquinoline that specifically inhibits mycobacterial ATP synthase, active against both drug-susceptible and drug-resistant M. tuberculosis, core of the WHO BPaL MDR-TB regimen. Key Therapeutic Uses: � MDR-TB and XDR-TB � WHO recommended core drug � BPaL regimen (Bedaquiline + Pretomanid + Linezolid) � RR-TB (rifampicin-resistant TB) � TB in HIV coinfected patients Available Strengths: 100 mg Product Highlights: � First new TB drug class in 40 years � WHO recommended core MDR-TB drug � WHO-GMP, DCGI approved � Widely supplied to national TB programs � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #BedaquilineTablet #SirturoGeneric #ATPSynthaseInhibitor #MDRTBTablet #XDRTBMedicine #BPaLRegimen #BedaquilineManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Shelcal (Calcium Carbonate + Vitamin D3) Tablet Calcium & Vitamin D3 for Bone Health Narix Pharmaceuticals Narix Pharmaceuticals manufactures Calcium Carbonate + Cholecalciferol (D3) Tablets � India's highest-volume calcium supplement combining the most bioavailable form of calcium with Vitamin D3 for optimal intestinal calcium absorption and bone mineralization. Key Therapeutic Uses: � Osteoporosis � calcium and vitamin D supplementation � Calcium deficiency � dietary supplementation � Pregnancy and lactation � increased calcium requirement � Rickets and osteomalacia � alongside vitamin D therapy � Adjunct to bisphosphonate and SERM therapy Available Strengths: Calcium 500/1000 mg + D3 250/500 IU Product Highlights: � India's highest-volume calcium supplement � WHO-GMP, DCGI approved � Multiple strength combinations available � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #CalciumCarbonateD3Tablet #ShelcalGeneric #CalcimaxGeneric #CalciumSupplement #BoneHealthTablet #VitaminD3Tablet #CalciumManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Malarone (Atovaquone + Proguanil) Tablet Best-Tolerated Antimalarial for Travel Prophylaxis Narix Pharmaceuticals Narix Pharmaceuticals manufactures Atovaquone + Proguanil FDC Tablets � the best-tolerated antimalarial prophylaxis for travelers, with a short pre/post travel dosing window and the unique ability to target both liver and blood stages. Key Therapeutic Uses: � Malaria chemoprophylaxis � first choice for short travel � Uncomplicated P. falciparum malaria treatment � Chloroquine-resistant malaria Available Strengths: Atovaquone 250 mg + Proguanil 100 mg (adult) 62.5/25 mg (pediatric) Product Highlights: � Only day before/7 days after prophylaxis � shortest window � Best-tolerated antimalarial prophylaxis � Causal prophylaxis � liver stage activity � WHO-GMP, DCGI approved � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #AtovaquoneProguanilTablet #MalaroneGeneric #MalariaProphylaxis #TravelAntimalarial #FalciparumTreatment #AtovaquoneManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Seromycin (Cycloserine) Capsule D-Alanine Analogue for MDR-TB & Group C TB Regimens Narix Pharmaceuticals Narix Pharmaceuticals supplies Cycloserine Capsules, a D-alanine analogue that inhibits mycobacterial cell wall synthesis � a WHO Group C MDR-TB drug used in longer MDR-TB regimens when core agents are not tolerated or when resistance is extensive. Key Therapeutic Uses: � MDR-TB � WHO Group C add-on drug � XDR-TB � component of individualized regimens � UTI caused by susceptible organisms (off-label) � Drug-susceptible TB � second-line when first-line fails Available Strengths: 250 mg Product Highlights: � WHO Group C MDR-TB medicine � WHO-GMP, DCGI approved � Requires therapeutic drug monitoring � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #CycloserineCapsule #SeromycinGeneric #CoxerinGeneric #MDRTBCapsule #WHOGroupCTB #CycloserineManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Theo Dur-(Theophylline) Tablet Classic Xanthine Bronchodilator for Asthma & COPD Narix Pharmaceuticals Narix Pharmaceuticals manufactures Theophylline SR Tablets, the classic oral bronchodilator with anti-inflammatory and immunomodulatory properties � WHO essential medicine widely used in LMIC markets for asthma and COPD. Key Therapeutic Uses: � Bronchial asthma � moderate-to-severe, nocturnal � COPD maintenance � oral bronchodilator � Chronic bronchitis with reversible bronchospasm � Apnea of prematurity (neonatal) Available Strengths: 100 mg 200 mg 300 mg SR 400 mg SR Product Highlights: � WHO essential medicine � EML listed � SR formulation for twice-daily dosing � High export demand in Africa and ASEAN � WHO-GMP, DCGI approved � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #TheophyllineTablet #TheoDurGeneric #XanthineBronchodilator #AsthmaTablet #COPDTablet #TheophyllineManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine #OralBronchodilator

Arava (Leflunomide) Tablet Disease-Modifying Anti-Rheumatic Drug for RA & PsA Narix Pharmaceuticals Narix Pharmaceuticals manufactures Leflunomide Tablets, a pyrimidine synthesis inhibitor DMARD providing disease modification in rheumatoid arthritis and psoriatic arthritis � inhibiting activated T-lymphocyte proliferation with efficacy comparable to methotrexate. Key Therapeutic Uses: � Rheumatoid arthritis � DMARD, comparable to methotrexate � Psoriatic arthritis � skin and joint disease modification � MTX-intolerant RA patients � Combined with methotrexate for refractory RA Available Strengths: 10 mg 20 mg 100 mg (loading dose) Product Highlights: � Efficacy comparable to methotrexate in RA � Once-daily dosing � high compliance � WHO-GMP, DCGI approved � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #LeflunomideTablet #AravaGeneric #LefnoGeneric #DMARD #RheumatoidArthritisTablet #PsoriaticArthritis #LeflunomideManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Requip (Ropinirole) Tablet Non-Ergot D2/D3 Agonist for Parkinson's Disease & RLS Narix Pharmaceuticals Narix Pharmaceuticals manufactures Ropinirole Tablets, a non-ergot selective D2/D3 dopamine receptor agonist used as Parkinson's disease monotherapy in early stages and adjunct in advanced PD, with FDA approval also for restless legs syndrome. Key Therapeutic Uses: � Parkinson's disease � early monotherapy and adjunct � Restless legs syndrome (RLS) � FDA-approved � Advanced PD � levodopa dose reduction � Dopamine agonist rotation from ergot derivatives Available Strengths: 0.25 mg 0.5 mg 1 mg 2 mg 3 mg 4 mg 5 mg (IR and XL) Product Highlights: � Non-ergot � no fibrosis risk � IR and XL formulations available � WHO-GMP, DCGI approved � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #RopiniroleTablet #RequipGeneric #RoparkGeneric #DopamineAgonist #ParkinsonsMedicine #RLSMedicine #RopiniroleManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Piriton (Chlorpheniramine) Tablet Classic Sedating Antihistamine for Allergy, Cold & Urticaria Narix Pharmaceuticals Narix Pharmaceuticals manufactures Chlorpheniramine Tablets, the most affordable and widely exported first-generation H1 antihistamine � WHO essential medicine used globally for allergy, cold symptoms, urticaria, and as a sedating antipruritic. Key Therapeutic Uses: � Allergic rhinitis and hay fever � Urticaria, pruritus, and allergic rashes � Common cold � sneezing and runny nose � Anaphylaxis � adjunct to epinephrine � Pruritus in chickenpox and dermatitis Available Strengths: 2 mg 4 mg Product Highlights: � WHO essential medicine � EML listed � Most affordable antihistamine globally � Very high export demand in Africa and ASEAN � WHO-GMP, DCGI approved � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #ChlorpheniramineTablet #PiritonGeneric #CTMTablet #FirstGenAntihistamine #AllergicRhinitis #ColdTablet #ChlorpheniramineManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Campral (Acamprosate) Tablet Anti-Craving Agent for Alcohol Use Disorder Abstinence Narix Pharmaceuticals Narix Pharmaceuticals manufactures Acamprosate Tablets, a synthetic homotaurine derivative that modulates GABA and glutamate neurotransmission � reducing alcohol craving and supporting sustained abstinence without abuse potential or sedation. Key Therapeutic Uses: � Alcohol use disorder � maintenance of abstinence � Alcohol craving reduction post-detoxification � Prevention of alcohol relapse after detox � Adjunct to psychological support programs Available Strengths: 333 mg (enteric-coated) Product Highlights: � No sedation, no abuse potential � safe long-term � Reduces NMDA-mediated glutamate excitotoxicity (anti-craving) � WHO-GMP, DCGI approved � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #AcamprosateTablet #CampralGeneric #AntiCravingTablet #AlcoholAbstinence #DeAddictionTablet #AlcoholRelapsePrevention #AcamprosateManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Pepcid (Famotidine) Tablet Potent H2 Blocker for GERD, Ulcers & Acid Reflux Narix Pharmaceuticals Narix Pharmaceuticals manufactures Famotidine Tablets, a potent H2 receptor antagonist � 8x more potent than ranitidine and 20x more potent than cimetidine � used for GERD, peptic ulcers, and as a safe antacid alternative with no CYP450 drug interactions. Key Therapeutic Uses: � Peptic ulcer disease � gastric and duodenal � GERD and acid reflux � maintenance and acute � Zollinger-Ellison syndrome � Prevention of stress ulcers in ICU � Gastritis � acute and chronic � COVID-19 � early investigated as H2 blocker Available Strengths: 20 mg 40 mg Product Highlights: � No CYP450 interactions � superior to cimetidine � WHO-GMP, DCGI approved � OTC and prescription formulations available � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #FamotidineTablet #PepcidGeneric #FamocidGeneric #H2Blocker #GERDMedicine #PepticUlcerTablet #FamotidineManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine #AcidReflux

Reyataz (Atazanavir) Capsule Once-Daily Protease Inhibitor with Favourable Lipid Profile Narix Pharmaceuticals Narix Pharmaceuticals supplies Atazanavir Capsules, the only once-daily unboosted protease inhibitor with the most favorable lipid profile among PIs � preferred in HIV patients concerned about dyslipidemia or cardiovascular risk. Key Therapeutic Uses: � HIV-1 infection � first and second-line PI option � Once-daily HIV ART regimen (boosted with cobicistat/ritonavir) � HIV with dyslipidemia � lipid-neutral PI � Treatment-experienced HIV patients Available Strengths: 150 mg 200 mg 300 mg 400 mg Product Highlights: � Favorable lipid profile � lipid-neutral PI � Once-daily dosing � highest PI compliance � WHO-GMP, DCGI approved � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #AtazanavirCapsule #ReyatazGeneric #AtazorGeneric #HIVProteasInhibitor #OnceDailyPI #LipidNeutralHIV #AtazanavirManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Olumiant (Baricitinib) Tablet JAK1/2 Inhibitor for RA, Alopecia Areata & Atopic Dermatitis Narix Pharmaceuticals Narix Pharmaceuticals manufactures Baricitinib Tablets, a selective JAK1/2 inhibitor � the first JAK inhibitor FDA-approved for alopecia areata and with broad evidence across RA, atopic dermatitis, and COVID-19 hospitalized patients. Key Therapeutic Uses: � Rheumatoid arthritis � moderate-to-severe, MTX-inadequate response � Alopecia areata � FDA-approved (first JAK for hair loss) � Moderate-to-severe atopic dermatitis � FDA-approved � COVID-19 � hospitalized patients (FDA authorized) Available Strengths: 1 mg 2 mg 4 mg Product Highlights: � First JAK inhibitor for alopecia areata � breakthrough approval � Once-daily dosing � oral convenience vs biologics � WHO-GMP, DCGI approved � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #BaricitinibTablet #OlumiantGeneric #JAK12Inhibitor #RheumatoidArthritisTablet #AlopeciaAreataTablet #AtopicDermatitis #BaricitinibManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Ovacare (Myo-Inositol + D-Chiro Inositol) Tablet Dual Inositol Therapy for PCOS & Ovulation Induction Narix Pharmaceuticals Narix Pharmaceuticals manufactures Myo-Inositol + D-Chiro Inositol (40:1 ratio) Tablets, the evidence-based nutraceutical combination for PCOS management � improving insulin sensitivity, restoring menstrual cyclicity, and enhancing ovulation quality. Key Therapeutic Uses: � Polycystic ovary syndrome (PCOS) � insulin sensitization � Ovulation induction � improves oocyte quality � Menstrual irregularity in PCOS � Infertility associated with PCOS � Gestational diabetes prevention in PCOS pregnancy Available Strengths: Myo-Inositol 1000 mg + D-Chiro Inositol 25 mg (40:1 ratio) Product Highlights: � Evidence-based PCOS treatment � 40:1 physiological ratio � WHO-GMP, DCGI approved � No hormonal side effects � safe long-term � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #MyoInositolTablet #OvacareGeneric #PCOCareGeneric #PCOSTablet #InositolTherapy #OvulationInduction #InositolManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Vimovo (Esomeprazole + Aspirin) Tablet Gastroprotective PPI + Aspirin FDC for Chronic Aspirin Users Narix Pharmaceuticals Narix Pharmaceuticals manufactures Esomeprazole + Aspirin Fixed-Dose Combination Tablets providing simultaneous gastric mucosal protection (Esomeprazole) and anti-platelet/anti-inflammatory therapy (Aspirin) � designed for patients requiring chronic aspirin therapy who are at risk of GI complications. Key Therapeutic Uses: � Cardiovascular disease prevention with aspirin � gastroprotected formulation � NSAID-associated ulcer prevention in chronic aspirin users � Secondary CV prevention requiring daily aspirin + PPI � Aspirin use in patients with peptic ulcer history Available Strengths: Esomeprazole 20 mg + Aspirin 75/100/150 mg Product Highlights: � Simultaneous gastroprotection and antiplatelet therapy � WHO-GMP, DCGI approved � Single-pill compliance for cardiology patients � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #EsomeprazoleAspirinTablet #VimovoGeneric #GastroprotectedAspirin #CardiovascularGIProtection #PPIAspirinFDC #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Cancidas (Caspofungin) Oral Tablet First Echinocandin for Aspergillosis & Candidiasis Narix Pharmaceuticals Narix Pharmaceuticals manufactures Caspofungin Oral Tablets (step-down), the first FDA-approved echinocandin with proven efficacy against both Candida and Aspergillus � the reference drug in its class. Key Therapeutic Uses: � Invasive candidiasis and candidemia � Salvage therapy for refractory aspergillosis � Esophageal candidiasis � Empirical antifungal therapy in febrile neutropenic patients Available Strengths: Oral step-down per physician guidance Product Highlights: � First-in-class echinocandin � reference drug � Activity against Candida and Aspergillus � WHO-GMP, DCGI approved � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #CaspofunginTablet #CancidasGeneric #FirstEchinocandin #CandidiasisTablet #AspergillosisSalvage #CaspofunginManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Razo D-(Rabeprazole + Domperidone) Tablet PPI + Prokinetic FDC for GERD & Dyspepsia Narix Pharmaceuticals Narix Pharmaceuticals manufactures Rabeprazole + Domperidone Fixed-Dose Combination Tablets, one of India's most prescribed GI FDCs � combining PPI acid suppression with prokinetic motility enhancement for comprehensive GERD and dyspepsia management. Key Therapeutic Uses: � GERD with delayed gastric emptying � Functional dyspepsia with acid component � Heartburn with bloating and nausea � Post-meal regurgitation and belching � Gastritis with motility disorder Available Strengths: Rabeprazole 10/20 mg + Domperidone 10/30 mg SR Product Highlights: � India's top GI FDC � Razo-D/Rablet-D among highest Rx volume � Dual action � acid suppression + gastric motility � WHO-GMP, DCGI approved � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #RabeprazoleDomperidoneTablet #RazoDGeneric #PPIProKineticFDC #GERDDyspepsia #AcidRefluxTablet #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine #IndiaTopGIFDC